Methylglyoxal modulates endothelial nitric oxide synthase-associated functions in EA.hy926 endothelial cells

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Su, Yang ^a   Qadri, Syed M ^a   Wu, Lingyun ^b   Liu, Lixin ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Biopterins; eNOS phosphorylation; eNOS uncoupling; Methylglyoxal; Superoxide; Tyrosine nitration

Indexed keywords

3 NITROTYROSINE; BIOPTERIN; DIMER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METHYLGLYOXAL; MONOMER; N(G) NITROARGININE METHYL ESTER; OXYGEN; PEROXYNITRITE; SEPIAPTERIN; SERINE; SUPEROXIDE; TEMPOL; TETRAHYDROBIOPTERIN; TYROSINE;

ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME PHOSPHORYLATION; FLUORESCENCE ANALYSIS; FLUOROMETRY; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NITRATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIOXIDANTS; BIOPTERIN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PEROXYNITROUS ACID; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PYRUVALDEHYDE; SUPEROXIDES; TIME FACTORS; TYROSINE;

EID: 84884224730     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-134     Document Type: Article

References (71)

1. Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 2007, 4:84-88.
2. Kitasato L, Tojo T, Hatakeyama Y, Kameda R, Hashikata T, Yamaoka-Tojo M. Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide. Cardiovasc Diabetol 2012, 11:79. 10.1186/1475-2840-11-79, 3492036, 22748110.
3. Chen X, Mori T, Guo Q, Hu C, Ohsaki Y, Yoneki Y, et al. Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats. Hypertens Res 2013, 36:361-367. 10.1038/hr.2012.204, 3619051, 23364337.
4. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G, et al. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 2006, 18:223-232. 10.1159/000097669, 17167227.
5. Gawlowski T, Stratmann B, Stirban AO, Negrean M, Tschoepe D. AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation. Thromb Res 2007, 121:117-126. 10.1016/j.thromres.2007.03.002, 17445870.
6. Price CL, Hassi HO, English NR, Blakemore AI, Stagg AJ, Knight SC. Methylglyoxal modulates immune responses: relevance to diabetes. J Cell Mol Med 2010, 14:1806-1815.
7. Kuntz S, Kunz C, Rudloff S. Carbonyl compounds methylglyoxal and glyoxal affect interleukin-8 secretion in intestinal cells by superoxide anion generation and activation of MAPK p38. Mol Nutr Food Res 2010, 54:1458-1467. 10.1002/mnfr.200900408, 20397192.
8. Jan CR, Chen CH, Wang SC, Kuo SY. Effect of methylglyoxal on intracellular calcium levels and viability in renal tubular cells. Cell Signal 2005, 17:847-855. 10.1016/j.cellsig.2004.11.007, 15763427.
9. Wang H, Liu J, Wu L. Methylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells. Biochem Pharmacol 2009, 77:1709-1716. 10.1016/j.bcp.2009.02.024, 19428325.
10. Su Y, Lei X, Wu L, Liu L. The role of endothelial cell adhesion molecules P-selectin, E-selectin and intercellular adhesion molecule-1 in leucocyte recruitment induced by exogenous methylglyoxal. Immunology 2012, 137:65-79. 10.1111/j.1365-2567.2012.03608.x, 3449248, 22681228.
11. Chan WH, Wu HJ. Methylglyoxal and high glucose co-treatment induces apoptosis or necrosis in human umbilical vein endothelial cells. J Cell Biochem 2008, 103:1144-1157. 10.1002/jcb.21489, 17721990.
12. Tejero J, Stuehr D. Tetrahydrobiopterin in nitric oxide synthase. IUBMB Life 2013, 65:358-365. 10.1002/iub.1136, 23441062.
13. Buckley BJ, Mirza Z, Whorton AR. Regulation of Ca(2+)-dependent nitric oxide synthase in bovine aortic endothelial cells. Am J Physiol 1995, 269:C757-C765.
14. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1-R12.
15. Wheatcroft SB, Williams IL, Shah AM, Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 2003, 20:255-268. 10.1046/j.1464-5491.2003.00869.x, 12675638.
16. Montezano AC, Touyz RM. Reactive oxygen species and endothelial function-role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol 2012, 110:87-94. 10.1111/j.1742-7843.2011.00785.x, 21883939.
17. Ravi K, Brennan LA, Levic S, Ross PA, Black SM. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc Natl Acad Sci USA 2004, 101:2619-2624. 10.1073/pnas.0300464101, 356999, 14983058.
18. Sawabe K, Yamamoto K, Harada Y, Ohashi A, Sugawara Y, Matsuoka H, et al. Cellular uptake of sepiapterin and push-pull accumulation of tetrahydrobiopterin. Mol Genet Metab 2008, 94:410-416. 10.1016/j.ymgme.2008.04.007, 18511317.
19. Shimazu T, Otani H, Yoshioka K, Fujita M, Okazaki T, Iwasaka T. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction. Am J Physiol Heart Circ Physiol 2011, 301:H2061-H2072. 10.1152/ajpheart.00525.2011, 21890687.
20. Lorin J, Zeller M, Guilland JC, Cottin Y, Vergely C, Rochette L. Arginine and nitric oxide synthase: Regulatory mechanisms and cardiovascular aspects. Mol Nutr Food Res 2013, 10.1002/mnfr.201300033.
21. Kietadisorn R, Juni RP, Moens AL. Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab 2012, 302:E481-E495. 10.1152/ajpendo.00540.2011, 22167522.
22. Srivastava K, Bath PM, Bayraktutan U. Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke. Cell Mol Neurobiol 2012, 32:319-336. 10.1007/s10571-011-9777-z, 22198555.
23. Cai S, Khoo J, Mussa S, Alp NJ, Channon KM. Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia 2005, 48:1933-1940. 10.1007/s00125-005-1857-5, 16034613.
24. Shevalye H, Watcho P, Stavniichuk R, Dyukova E, Lupachyk S, Obrosova IG. Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats. Diabetes 2012, 61:2126-2133. 10.2337/db11-1524, 3402301, 22751692.
25. Stalker TJ, Gong Y, Scalia R. The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes. Diabetes 2005, 54:1132-1140. 10.2337/diabetes.54.4.1132, 15793253.
26. Desai KM, Chang T, Wang H, Banigesh A, Dhar A, Liu J, et al. Oxidative stress and aging: is methylglyoxal the hidden enemy?. Can J Physiol Pharmacol 2010, 88:273-284. 10.1139/Y10-001, 20393592.
27. Lin X, Amore A, Loiacono E, Balegno S, Manniello D, Peruzzi L, et al. Effect of glucose degradation products, glucose-containing dialysate and icodextrin on AQP1 and eNOS expression in cultured endothelial cells. J Nephrol 2009, 22:117-122.
28. Wang X, Jia X, Chang T, Desai K, Wu L. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J Hypertens 2008, 26:765-772. 10.1097/HJH.0b013e3282f4a13c, 18327087.
29. Mukohda M, Morita T, Okada M, Hara Y, Yamawaki H. Long-term methylglyoxal treatment causes endothelial dysfunction of rat isolated mesenteric artery. J Vet Med Sci 2013, 75:151-157. 10.1292/jvms.12-0345, 23018793.
30. Dhar A, Dhar I, Desai KM, Wu L. Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose. Br J Pharmacol 2010, 161:1843-1856. 10.1111/j.1476-5381.2010.01017.x, 3010587, 20825408.
31. Sankaralingam S, Xu H, Jiang Y, Sawamura T, Davidge ST. Evidence for increased methylglyoxal in the vasculature of women with preeclampsia: role in upregulation of LOX-1 and arginase. Hypertension 2009, 54:897-904. 10.1161/HYPERTENSIONAHA.109.135228, 19687346.
32. Targosz-Korecka M, Brzezinka GD, Malek KE, Stepien E, Szymonski M. Stiffness memory of EA.hy926 endothelial cells in response to chronic hyperglycemia. Cardiovasc Diabetol 2013, 12:96. 10.1186/1475-2840-12-96, 3707738, 23806077.
33. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. Circ Res 2000, 86:E36-E41. 10.1161/01.RES.86.2.e36, 10666424.
34. Woo HJ, Kang JY, Choi YK, Park YS. Production of sepiapterin in Escherichia coli by coexpression of cyanobacterial GTP cyclohydrolase I and human 6-pyruvoyltetrahydropterin synthase. Appl Environ Microbiol 2002, 68:3138-3140. 10.1128/AEM.68.6.3138-3140.2002, 123912, 12039779.
35. Yang YM, Huang A, Kaley G, Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol 2009, 297:H1829-H1836. 10.1152/ajpheart.00230.2009, 2781386, 19767531.
36. Chang T, Wang R, Wu L. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radic Biol Med 2005, 38:286-293. 10.1016/j.freeradbiomed.2004.10.034, 15607912.
37. Wang H, Meng QH, Chang T, Wu L. Fructose-induced peroxynitrite production is mediated by methylglyoxal in vascular smooth muscle cells. Life Sci 2006, 79:2448-2454. 10.1016/j.lfs.2006.08.009, 16950408.
38. Batandier C, Fontaine E, Keriel C, Leverve XM. Determination of mitochondrial reactive oxygen species: methodological aspects. J Cell Mol Med 2002, 6:175-187. 10.1111/j.1582-4934.2002.tb00185.x, 12169203.
39. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 2001, 89:224-236. 10.1161/hh1501.094365, 11485972.
40. Price CL, Knight SC. Methylglyoxal: possible link between hyperglycaemia and immune suppression?. Trends Endocrinol Metab 2009, 20:312-317. 10.1016/j.tem.2009.03.010, 19709901.
41. Kang JH. Modification and inactivation of human Cu, Zn-superoxide dismutase by methylglyoxal. Mol Cells 2003, 15:194-199.
42. Di LS, Zimmitti V, Sebastiani P, Cervelli C, Falone S, Amicarelli F. Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons. Int J Biochem Cell Biol 2008, 40:245-257. 10.1016/j.biocel.2007.07.019, 17869161.
43. Chang T, Untereiner A, Liu J, Wu L. Interaction of methylglyoxal and hydrogen sulfide in rat vascular smooth muscle cells. Antioxid Redox Signal 2010, 12:1093-1100. 10.1089/ars.2009.2918, 19803740.
44. Kim HK, Ha SH, Han J. Potential therapeutic applications of tetrahydrobiopterin: from inherited hyperphenylalaninemia to mitochondrial diseases. Ann N Y Acad Sci 2010, 1201:177-182. 10.1111/j.1749-6632.2010.05623.x, 20649554.
45. Abudukadier A, Fujita Y, Obara A, Ohashi A, Fukushima T, Sato Y. Tetrahydrobiopterin has a glucose-lowering effect by suppressing hepatic gluconeogenesis in an endothelial nitric oxide synthase-dependent manner in diabetic mice. Diabetes 2013, 62:3033-3043. 10.2337/db12-1242, 23649519.
46. Okazaki T, Otani H, Shimazu T, Yoshioka K, Fujita M, Katano T, et al. Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. J Mol Cell Cardiol 2011, 50:534-544. 10.1016/j.yjmcc.2010.12.010, 21182845.
47. Khoo JP, Zhao L, Alp NJ, Bendall JK, Nicoli T, Rockett K, et al. Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension. Circulation 2005, 111:2126-2133. 10.1161/01.CIR.0000162470.26840.89, 15824200.
48. Foxton RH, Land JM, Heales SJ. Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms. Neurochem Res 2007, 32:751-756. 10.1007/s11064-006-9201-0, 17191137.
49. Cheng H, Wang H, Fan X, Paueksakon P, Harris RC. Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice. Kidney Int 2012, 82:1176-1183. 10.1038/ki.2012.248, 3473143,3473143, 22785174.
50. Thida M, Earl J, Zhao Y, Wang H, Tse CS, Vickers JJ, et al. Effects of sepiapterin supplementation and NOS inhibition on glucocorticoid-induced hypertension. Am J Hypertens 2010, 23:569-574. 10.1038/ajh.2010.27, 20186125.
51. Tiefenbacher CP, Lee CH, Kapitza J, Dietz V, Niroomand F. Sepiapterin reduces postischemic injury in the rat heart. Pflugers Arch 2003, 447:1-7. 10.1007/s00424-003-1131-y, 12905031.
52. Crabtree MJ, Brixey R, Batchelor H, Hale AB, Channon KM. Integrated redox sensor and effector functions for tetrahydrobiopterin- and glutathionylation-dependent endothelial nitric-oxide synthase uncoupling. J Biol Chem 2013, 288:561-569. 10.1074/jbc.M112.415992, 3537053, 23139420.
53. McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem 2000, 275:6123-6128. 10.1074/jbc.275.9.6123, 10692402.
54. Chen CA, Druhan LJ, Varadharaj S, Chen YR, Zweier JL. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J Biol Chem 2008, 283:27038-27047. 10.1074/jbc.M802269200, 2556006, 18622039.
55. Yamamoto E, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, Fukuda M, et al. Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation. Biochem Biophys Res Commun 2010, 403:258-263. 10.1016/j.bbrc.2010.11.008, 21059340.
56. Serizawa K, Yogo K, Aizawa K, Tashiro Y, Ishizuka N. Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats. Cardiovasc Diabetol 2011, 10:105. 10.1186/1475-2840-10-105, 3248842, 22107602.
57. Wenzel P, Schulz E, Oelze M, Muller J, Schuhmacher S, Alhamdani MS, et al. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic Biol Med 2008, 45:619-626. 10.1016/j.freeradbiomed.2008.05.009, 18539157.
58. Singh U, Devaraj S, Vasquez-Vivar J, Jialal I. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol 2007, 43:780-791. 10.1016/j.yjmcc.2007.08.015, 2771555, 17942113.
59. Ren J, Duan J, Thomas DP, Yang X, Sreejayan N, Sowers JR, et al. IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. Am J Physiol Regul Integr Comp Physiol 2008, 294:R793-R802. 10.1152/ajpregu.00713.2007, 18199585.
60. Hirata M, Serizawa K, Aizawa K, Yogo K, Tashiro Y, Takeda S, et al. 22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy. Nephrol Dial Transplant 2013, 28:1166-1174. 10.1093/ndt/gfs536, 23239833.
61. Cheng J, Ou JS, Singh H, Falck JR, Narsimhaswamy D, Pritchard KA, et al. 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. Am J Physiol Heart Circ Physiol 2008, 294:H1018-H1026. 10.1152/ajpheart.01172.2007, 18156192.
62. Ceriello A, Novials A, Ortega E, Canivell S, Pujadas G, La SL, et al. Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes. Cardiovasc Diabetol 2013, 12:97. 10.1186/1475-2840-12-97, 3699412, 23806096.
63. Johnston PC, Powell LA, McCance DR, Pogue K, McMaster C, Gilchrist S, et al. Placental protein tyrosine nitration and MAPK in type 1 diabetic pre-eclampsia: Impact of antioxidant vitamin supplementation. J Diabetes Complications 2013, 27:322-327. 10.1016/j.jdiacomp.2013.02.001, 23558107.
64. Osorio H, Coronel I, Arellano A, Pacheco U, Bautista R, Franco M, et al. Sodium-glucose cotransporter inhibition prevents oxidative stress in the kidney of diabetic rats. Oxid Med Cell Longev 2012, 201(2):542042.
65. Sakul A, Cumaoglu A, Aydin E, Ari N, Dilsiz N, Karasu C. Age- and diabetes-induced regulation of oxidative protein modification in rat brain and peripheral tissues: consequences of treatment with antioxidant pyridoindole. Exp Gerontol 2013, 48:476-484. 10.1016/j.exger.2013.02.028, 23470276.
66. Huynh K, Kiriazis H, Du XJ, Love JE, Gray SP, Jandeleit-Dahm KA, et al. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free Radic Biol Med 2013, 60:307-317.
67. Ding Y, Vaziri ND, Coulson R, Kamanna VS, Roh DD. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab 2000, 279:E11-E17.
68. Okon EB, Chung AW, Rauniyar P, Padilla E, Tejerina T, McManus BM, et al. Compromised arterial function in human type 2 diabetic patients. Diabetes 2005, 54:2415-2423. 10.2337/diabetes.54.8.2415, 16046309.
69. Lu X, Guo X, Karathanasis SK, Zimmerman KM, Onyia JE, Peterson RG, et al. Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats. Cardiovasc Diabetol 2010, 9:19. 10.1186/1475-2840-9-19, 2891691, 20482873.
70. Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, et al. Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol 2005, 146:1110-1118. 1751246, 16231005.
71. Pannirselvam M, Ding H, Anderson TJ, Triggle CR. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur J Pharmacol 2006, 551:98-107. 10.1016/j.ejphar.2006.08.086, 17027963.